Telehealth patients missing out on pathology While telehealth use has risen sharply, these patients are less likely to access pathology services, a new study suggests.
Two more AstraZeneca-linked deaths in past week: TGA The latest fatalities mean Australia has now recorded nine deaths linked to the vaccine, compared to more than 1000 COVID deaths.
Guillain-Barre Syndrome warning for AstraZeneca The TGA has updated the vaccine’s Product Information regarding the ‘very rare’ possibility of contracting the disorder.
Blood pressure variability linked to dementia risk The findings may help identify people at increased risk of major cognitive impairment and inform new areas for research.
DoH releases primary care guidelines for vaccine blood clots The Department of Health document outlines possible presentations, symptoms and signs to look out for, as well as initial investigations.
Could a routine blood test improve dementia outcomes? Researchers are hoping a simple blood protein point-of-care test will aid early detection of cognitive impairment.
DoH confirms vaccine indemnity scheme, but questions remain ‘You shouldn’t fear that you’re going to get tied up in complicated litigation if something – despite your best efforts – goes wrong,’ the DoH First Assistant Secretary has told GPs.
National Cabinet announces no-fault indemnity scheme for GPs to administer AstraZeneca The move opens the door for under-60s to receive the vaccine as the country looks to speed up the rollout amid a potential national outbreak.
New AstraZeneca guidance reinforces need for vaccine counselling MBS numbers The decision to limit the use of AstraZeneca’s COVID vaccine to only people aged 60 and older will likely place more pressure on GPs dealing with vaccine-hesitant patients.
History of blood clots not usually a reason to avoid AstraZeneca Patients who have had blood clots or take blood thinners often ask these two haematologists, ‘Should I have the AstraZeneca vaccine?’